NORTREL 0.5 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nortrel 0.5, and when can generic versions of Nortrel 0.5 launch?
Nortrel 0.5 is a drug marketed by Barr and Barr Labs and is included in two NDAs.
The generic ingredient in NORTREL 0.5 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NORTREL 0.5?
- What are the global sales for NORTREL 0.5?
- What is Average Wholesale Price for NORTREL 0.5?
Summary for NORTREL 0.5
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| DailyMed Link: | NORTREL 0.5 at DailyMed |
US Patents and Regulatory Information for NORTREL 0.5
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | NORTREL 0.5/35-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 072692-001 | Feb 28, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Barr Labs | NORTREL 0.5/35-28 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 072695-001 | Feb 28, 1992 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
